Submission to court in the challenge to FDA deeming rule

August 2016: United States

Letter

Submission to court in the challenge to FDA deeming rule
A brief of amici curiae in the case of Nicopure et al vs FDA – the brief argues that FDA’s cost-benefit analysis has no material benefits and ignores huge health costs and unintended consequences. With 15 experts.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top